Clasp Therapeutics raised $150M in a Series A financing led by Novo Holdings, Third Rock, and Catalio to develop next-generation personalized and off-the-shelf immunotherapies targeting hard-to-treat tumors.
Amount Raised
$150 Million
Round Type
Series A
RockvilleBiotechnologyHealth CareTherapeuticsInvestors
Description
Clasp Therapeutics launched with $150 million in Series A financing to develop a portfolio of next-generation immunotherapies that are both personalized and off-the-shelf to target hard-to-treat tumors. The funding round was led by major investors Novo Holdings, Third Rock, and Catalio, with participation from the American Cancer Society’s philanthropic fund and others.
Quick answer
Clasp Therapeutics raised $150 Million in a Series A round, dated March 20, 2024. Investors: American Cancer Society’s Philanthropic Fund, Catalio, Third Rock and Novo Holdings. Clasp Therapeutics is based in Rockville, Maryland, United States.
- How much did Clasp Therapeutics raise?
- Clasp Therapeutics raised $150 Million in a Series A round on March 20, 2024.
- Who invested in Clasp Therapeutics?
- American Cancer Society’s Philanthropic Fund, Catalio, Third Rock and Novo Holdings are named as investors in this round.
- What does Clasp Therapeutics do?
- Clasp Therapeutics aims to bring absolute precision to immuno-oncology by developing next-generation T cell engagers (TCEs) that target tumor-specific oncogenic driver mutations across hard-to-treat cancers.
- Where is Clasp Therapeutics based and how big is it?
- Clasp Therapeutics is based in Rockville, Maryland, United States.
- Who are the decision-makers at Clasp Therapeutics?
- Fundz holds 1 contact at Clasp Therapeutics. Names and contact details are shown to Fundz members.
Source: Fundz verified event record.
Who else raised in Therapeutics and Biotechnology around the same time
Companies in the same sectors as Clasp Therapeutics that raised within 45 days of this round, from Fundz verified event records.
- Zenas BioPharma raised $200M on May 3, 2024.
- BridgeBio raised $200M (Pre-Seed) on May 3, 2024.
- Delphia Therapeutics raised $67M (Series A) on May 2, 2024.
- Novocure raised $400M (Debt Financing) on May 2, 2024.
- Scipher Medicine raised $25M on May 2, 2024.
- Medicenna raised $15M on April 30, 2024.
Who to call at Clasp Therapeutics, and when
A new round usually means Clasp Therapeutics is about to hire and buy. The teams that reach out first get the meeting.
- An alert the day Clasp Therapeutics raises, hires an executive or expands, scored against what you sell
- The decision-makers there, with verified emails
- Who you already know at Clasp Therapeutics, from your own LinkedIn network
Works inside ChatGPT and Claude. Ask who to call at Clasp Therapeutics. With Fundz connected, it knows.
AI made execution free. Knowing first is the whole game now.
Fundz sees it the moment Clasp Therapeutics raises, hires an exec or expands, usually minutes after it happens, and tells you who to reach.
Related People
Funding Insights
What this usually meansClasp Therapeutics raised. Fundz records a round at a median of 3.6 minutes from the SEC filing, with the decision-maker attached.
145 of these a day, filtered to the companies you pick, with the decision-maker attached.
5 screens from a live account. No signup.